Home > Browse Issues > Vol.39 No.2
Advance in Metabolomics Research in Biomarkers of Esophageal Cancer
Jiang Zhen1, Zhang Xin2, Wang Hanyan1, Hou Li1, Wei Ling2*
1Department of Biochemistry, North Sichuan Medical College, Nangchong 637000, China;
2Department of Biochemistry and Molecular Biology, School of Huaxi Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China
2Department of Biochemistry and Molecular Biology, School of Huaxi Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China
Abstract: Metabolomics， as a biotechnology widely used in fields such as disease， cancer， nutrition， drugs and microorganism in recent years， has become one of the focuses in “-omics” technology. Esophageal cancer (EC) is a malignance which is extremely harmful to the health of national residents. Metabolomics has made great progress in the screening of biomarkers of EC. This paper reviewed the researches about metabolomics and esophageal cancer in the last two decades to provide a reference basis for treatment and prediction of esophageal cancer.
CN
EN